Texas makes a stand against big pharma’s Covid vaccines

19 December 2023 - On the last day of November Texas launched extraordinary legal proceedings that could have wide-ranging political ...

Read more →

EU medicines agencies reflect on lessons learned from COVID-19

1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...

Read more →

ATAGI recommendations on use of the Moderna and Pfizer monovalent Omicron XBB.1.5 COVID-19 vaccines

20 November 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation on the use of XBB 1.5 COVID-19 vaccines. ...

Read more →

New Covid-19 vaccines available to target current variants

20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...

Read more →

End of COVID-19 emergency response

20 October 2023 - A statement from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency ...

Read more →

FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants

11 September 2023 - Today, the US FDA took action approving and authorising for emergency use updated COVID-19 vaccines formulated to ...

Read more →

FDA may approve new Covid boosters by Friday as deaths spike

6 September 2023 - The FDA could approve new Covid-19 vaccine boosters as soon as Friday, NBC reported Wednesday, offering more ...

Read more →

Additional COVID-19 vaccine dose recommended for adults 75 years and over

1 September 2023 - The Australian Government has accepted advice from the Australian Technical Advisory Group on Immunisation (ATAGI) that all ...

Read more →

Paving the way towards coordinated clinical trials in public health emergencies in the EU

25 July 2023 - EMA has published a report from a workshop that collected insights and suggestions for possible EU level ...

Read more →

EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants

6 June 2023 - The European Centre for Disease Prevention and Control and the European Medicines Agency have issued a ...

Read more →

ATAGI advice on the preferential use of bivalent COVID-19 vaccines for primary vaccination of people aged 12 years or older

30 May 2023 - ATAGI has made recommendations on the use of bivalent COVID-19 vaccines as a primary course. ...

Read more →

EMA and European medicines regulatory network lift COVID-19 business continuity status

10 May 2023 - EMA and the European medicines regulatory network are lifting their respective COVID-19 business continuity measures after successfully ...

Read more →

Statement from Emer Cooke on the end of the COVID-19 public health emergency

9 May 2023 - On Friday, the WHO Director General declared an end to the Public Health Emergency of International Concern ...

Read more →

COVID-19 vaccine safety report (6 April 2023)

6 April 2023 - To 2 April 2023, more than 44 million doses of Comirnaty (Pfizer) mRNA vaccines have been administered in ...

Read more →

Ensuring public trust in an empowered FDA

1 April 2023 - The FDA’s recent approval of lecanemab for Alzheimer’s disease has been clouded by controversy over other accelerated ...

Read more →